BioPorto AS (0JJM) Ratios
BioPorto AS Ratios
GB:0JJM's free cash flow for Q2 2026 was $-18.37M. For the 2026 fiscal year, GB:0JJM's free cash flow was increased by $0.00 and operating cash flow was $-18.37M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.25 | 4.12 | 3.24 | 3.27 | 2.59 |
| Quick Ratio | 2.90 | 3.89 | 3.09 | 3.19 | 2.48 |
| Cash Ratio | 2.10 | 2.93 | 2.62 | 2.64 | 1.84 |
| Solvency Ratio | -2.64 | -2.33 | -1.81 | -1.87 | -1.50 |
| Operating Cash Flow Ratio | -2.95 | -4.10 | -2.19 | -1.69 | -2.60 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -24.99 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 54.78M | $ 55.66M | $ 52.63M | $ 63.01M | $ 28.91M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.12 | 0.08 | 0.10 | 0.16 |
| Debt-to-Equity Ratio | 0.12 | 0.17 | 0.12 | 0.15 | 0.28 |
| Debt-to-Capital Ratio | 0.11 | 0.14 | 0.11 | 0.13 | 0.22 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.48 | 1.42 | 1.49 | 1.55 | 1.77 |
| Debt Service Coverage Ratio | -102.39 | -15.56 | -82.57 | -58.81 | -56.73 |
| Interest Coverage Ratio | -111.52 | -90.47 | -93.71 | -64.63 | -71.55 |
| Debt to Market Cap | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.03 | 0.02 | 0.04 | 0.05 |
| Net Debt to EBITDA | 0.56 | 0.69 | 1.02 | 0.93 | 0.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 69.54% | 67.68% | 65.19% | 65.73% | 62.01% |
| EBIT Margin | -216.12% | -201.17% | -195.87% | -277.74% | -259.45% |
| EBITDA Margin | -209.90% | -194.59% | -186.99% | -264.05% | -241.05% |
| Operating Profit Margin | -213.70% | -208.18% | -194.34% | -268.83% | -269.05% |
| Pretax Profit Margin | -217.53% | -203.47% | -197.71% | -281.50% | -263.21% |
| Net Profit Margin | -203.83% | -188.29% | -181.95% | -262.08% | -235.48% |
| Continuous Operations Profit Margin | -203.83% | -188.29% | -181.95% | -262.08% | -235.48% |
| Net Income Per EBT | 93.70% | 92.54% | 92.03% | 93.10% | 89.46% |
| EBT Per EBIT | 101.79% | 97.73% | 101.73% | 104.71% | 97.83% |
| Return on Assets (ROA) | -88.13% | -71.08% | -62.72% | -69.88% | -70.29% |
| Return on Equity (ROE) | -130.33% | -100.69% | -93.63% | -108.12% | -124.26% |
| Return on Capital Employed (ROCE) | -128.39% | -99.77% | -93.36% | -100.27% | -115.57% |
| Return on Invested Capital (ROIC) | -114.38% | -84.83% | -82.14% | -89.66% | -98.45% |
| Return on Tangible Assets | -88.26% | -71.28% | -63.04% | -70.38% | -71.21% |
| Earnings Yield | -14.98% | -10.85% | -7.52% | -9.88% | -8.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.80 | 3.79 | 9.36 | 6.30 | 3.06 |
| Payables Turnover | 0.88 | 2.05 | 1.56 | 0.95 | 2.16 |
| Inventory Turnover | 1.33 | 2.52 | 2.85 | 3.88 | 3.39 |
| Fixed Asset Turnover | 6.35 | 4.16 | 14.25 | 6.42 | 1.70 |
| Asset Turnover | 0.43 | 0.38 | 0.34 | 0.27 | 0.30 |
| Working Capital Turnover Ratio | 0.66 | 0.60 | 0.49 | 0.53 | 0.36 |
| Cash Conversion Cycle | -45.87 | 63.01 | -66.63 | -232.50 | 58.02 |
| Days of Sales Outstanding | 96.05 | 96.23 | 38.98 | 57.93 | 119.11 |
| Days of Inventory Outstanding | 275.07 | 144.59 | 128.27 | 94.05 | 107.68 |
| Days of Payables Outstanding | 416.99 | 177.81 | 233.88 | 384.49 | 168.77 |
| Operating Cycle | 371.12 | 240.82 | 167.25 | 151.99 | 226.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.14 | -0.21 | -0.15 | -0.16 | -0.23 |
| Free Cash Flow Per Share | -0.14 | -0.21 | -0.15 | -0.16 | -0.23 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -238.81 | -1421.95 | -111.43 | -166.01 |
| Capital Expenditure Coverage Ratio | 0.00 | -238.81 | -1421.95 | -111.43 | -166.01 |
| Operating Cash Flow Coverage Ratio | -10.25 | -7.47 | -7.65 | -4.93 | -4.95 |
| Operating Cash Flow to Sales Ratio | -1.91 | -2.31 | -1.79 | -1.81 | -2.66 |
| Free Cash Flow Yield | -14.06% | -13.35% | -7.41% | -6.89% | -9.46% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.80 | -9.22 | -13.30 | -10.12 | -12.03 |
| Price-to-Sales (P/S) Ratio | 13.61 | 17.35 | 24.20 | 26.52 | 28.32 |
| Price-to-Book (P/B) Ratio | 8.70 | 9.28 | 12.45 | 10.94 | 14.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.11 | -7.49 | -13.50 | -14.51 | -10.57 |
| Price-to-Operating Cash Flow Ratio | -7.11 | -7.52 | -13.51 | -14.64 | -10.64 |
| Price-to-Earnings Growth (PEG) Ratio | 0.58 | -1.47 | 0.44 | -1.06 | 0.44 |
| Enterprise Value Multiple | -5.92 | -8.23 | -11.92 | -9.12 | -11.19 |
| Enterprise Value | 500.90M | 580.44M | 690.11M | 697.24M | 654.30M |
| EV to EBITDA | -5.92 | -8.23 | -11.92 | -9.12 | -11.19 |
| EV to Sales | 12.43 | 16.02 | 22.29 | 24.07 | 26.98 |
| EV to Free Cash Flow | -6.50 | -6.92 | -12.44 | -13.17 | -10.07 |
| EV to Operating Cash Flow | -6.50 | -6.94 | -12.44 | -13.28 | -10.13 |
| Tangible Book Value Per Share | 0.12 | 0.17 | 0.17 | 0.21 | 0.16 |
| Shareholders’ Equity Per Share | 0.12 | 0.17 | 0.17 | 0.21 | 0.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.06 | 0.07 | 0.08 | 0.07 | 0.11 |
| Revenue Per Share | 0.07 | 0.09 | 0.09 | 0.09 | 0.09 |
| Net Income Per Share | -0.15 | -0.17 | -0.16 | -0.23 | -0.21 |
| Tax Burden | 0.94 | 0.93 | 0.92 | 0.93 | 0.89 |
| Interest Burden | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Research & Development to Revenue | 1.24 | 0.93 | 0.82 | 1.21 | 1.25 |
| SG&A to Revenue | 1.59 | 1.83 | 1.16 | 1.44 | 1.35 |
| Stock-Based Compensation to Revenue | -0.02 | -0.02 | 0.04 | 0.26 | -0.04 |
| Income Quality | 0.94 | 1.11 | 0.98 | 0.64 | 0.99 |
Currency in DKK